BIOA BioAge Labs, Inc. - Common Stock
$10,85
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$4–$26
30% of range
Analystenbewertung
STRONG BUY
15 analysts
Kursziel
$36
+228% upside
P/E (TTM)
-5.8
ROE
-28.4%
Nettogewinnmarge
-896.1%
BIOA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$10.85
Marktkapitalisierung
$482M
P/E (TTM)
-5.8
EPS (TTM)
$-2.24
Umsatz (TTM)
$9M
Dividendenrendite
—
ROE
-28.4%
Verschuldungsgrad
0.0
52W-Spanne
$4 – $26
BIOA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$9M
2024-12-31
→
2025-12-31
EPS
$-2.24
2023-12-31
→
2025-12-31
Freier Cashflow
$-82M
2024-12-31
→
2025-12-31
Margen
-896.1%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
BIOA
Peer-Median
P/E (TTM)
-5.8
11.7
P/S (TTM) (K/V (TTM))
53.5
5.4
P/B (K/B)
1.8
3.7
EV / EBITDA
-2.2
—
Price / FCF (Kurs / FCF)
-5.8
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
BIOA
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-1031.5%
—
Net Profit Margin (Nettogewinnmarge)
-896.1%
-45.6%
ROA
-24.7%
-25.4%
ROE
-28.4%
-27.1%
ROIC
-33.8%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
BIOA
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.0
—
Current Ratio (Liquiditätsgrad)
14.2
4.6
Quick Ratio
14.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
BIOA
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
BIOA
Peer-Median
BIOA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 6 40,0%
- Kauf 6 40,0%
- Halten 3 20,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-17
Median
$30.00
Mittelwert
$35.62
← Unter allen Zielen
$10.85
Tief
$20.00
Hoch
$73.00
Median-Ziel
$30.00
+176,5%
Mittelwert-Ziel
$35.62
+228,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.07%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.58 | $-0.62 | 0.04% |
| 31. März 2026 | $-0.52 | $-0.65 | 0.13% |
| 31. Dezember 2025 | $-0.72 | $-0.75 | 0.03% |
| 30. September 2025 | $-0.56 | $-0.60 | 0.04% |
| 30. Juni 2025 | $-0.60 | $-0.49 | -0.11% |
| 31. März 2025 | $-0.36 | $-0.54 | 0.18% |
| 31. Dezember 2024 | $-1.97 | $-2.12 | 0.15% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $9M | $0 | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $28M | $19M | |
| Operating Expenses | $102M | $78M | |
| Operating Income | $-93M | $-78M | |
| Other Non-op | $12M | $7M | |
| Pretax Income | $-81M | $-71M | |
| Income Tax | $0 | $0 | |
| Net Income | $-81M | $-71M | |
| EPS (Basic) | $-2.24 | $-6.63 | |
| EPS (Diluted) | $-2.24 | $-6.63 | |
| Shares (Basic) | 35,932,914 | 10,726,521 | |
| Shares (Diluted) | 35,932,914 | 10,726,521 | |
| EBITDA | $-93M | $-78M |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $354M | |
| Short-term Investments | $92M | $0 | |
| Receivables | $769.0K | $0 | |
| Prepaid Expense | $5M | $3M | |
| Current Assets | $287M | $357M | |
| PP&E (Net) | $963.0K | $591.0K | |
| PP&E (Gross) | $1M | $962.0K | |
| Accum. Depreciation | $482.0K | $371.0K | |
| Other Non-current Assets | $216.0K | $240.0K | |
| Total Assets | $295M | $358M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $20M | $28M | |
| Capital Leases | $2M | $0 | |
| Total Liabilities | $23M | $35M | |
| Long-term Debt | $3M | $9M | |
| Total Debt | $3M | $9M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $605M | $576M | |
| Retained Earnings | $-333M | $-253M | |
| AOCI | $278.0K | $245.0K | |
| Stockholders' Equity | $272M | $323M | |
| Liabilities + Equity | $295M | $358M | |
| Shares Outstanding | 37,386,908 | 35,850,037 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $12M | $7M | |
| Operating Cash Flow | $-82M | $-52M | |
| CapEx | $719.0K | $366.0K | |
| Investing Cash Flow | $-95M | $-366.0K | |
| Stock Issued | $17M | $0 | |
| Net Stock Activity | $17M | · | |
| Financing Cash Flow | $11M | $381M | |
| Net Change in Cash | $-165M | $329M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-82M | $-52M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1031.5% | · | |
| Net Margin | -896.1% | · | |
| Pretax Margin | -896.1% | · | |
| EBITDA Margin | -1031.5% | · | |
| ROA | -24.7% | -37.0% | |
| ROE | -28.4% | -22.3% | |
| ROIC | -33.8% | -23.6% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.2 | 12.9 | |
| Quick Ratio | 14.0 | 12.8 | |
| Debt / Equity | 0.0 | 0.0 | |
| LT Debt / Equity | 0.0 | 0.0 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 23.4 | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $9M | $0 | |
| Net Income TTM | $-81M | $-71M | |
| Market Cap | $495M | $208M | |
| Enterprise Value | $216M | $-138M | |
| P/E | -5.9 | -0.9 | |
| P/S | 55.0 | · | |
| P/B | 1.8 | 0.6 | |
| P / Tangible Book | 1.8 | 0.6 | |
| P / Cash Flow | -6.1 | -4.0 | |
| P / FCF | -6.0 | -4.0 | |
| EV / EBITDA | -2.3 | 1.8 | |
| EV / FCF | -2.6 | 2.7 | |
| EV / Revenue | 24.0 | · | |
| Earnings Yield | -16.9% | -114.5% |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $3M | $3M | $2M | $2M | $1M | $0 | $0 | $0 | |
| R&D Expense | $24M | $20M | $24M | $19M | $20M | $11M | $19M | $20M | $10M | |
| SG&A Expense | $7M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | |
| Operating Expenses | $32M | $28M | $32M | $25M | $27M | $18M | $25M | $25M | $15M | |
| Operating Income | $-29M | $-25M | $-28M | $-23M | $-25M | $-16M | $-25M | $-25M | $-15M | |
| Other Non-op | $3M | $3M | $2M | $3M | $3M | $4M | $4M | $1M | $2M | |
| Net Income | $-26M | $-22M | $-26M | $-20M | $-22M | $-13M | $-21M | $-23M | $-14M | |
| EPS (Basic) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| EPS (Diluted) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| Shares (Basic) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| Shares (Diluted) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| EBITDA | $-29M | $-25M | · | $-23M | $-25M | $-16M | · | $-25M | · |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $242M | $189M | $216M | $220M | $257M | $354M | $334M | · | |
| Short-term Investments | $245M | $141M | $92M | $70M | $77M | $63M | $0 | · | · | |
| Receivables | $625.0K | $709.0K | $769.0K | $515.0K | $603.0K | $361.0K | $0 | · | · | |
| Prepaid Expense | $11M | $8M | $5M | $5M | $4M | $4M | $3M | $2M | · | |
| Current Assets | $330M | $392M | $287M | $291M | $302M | $325M | $357M | $336M | · | |
| PP&E (Net) | $1M | $1M | $963.0K | $973.0K | $974.0K | $929.0K | $591.0K | $543.0K | · | |
| PP&E (Gross) | $2M | $2M | $1M | $1M | $1M | $1M | $962.0K | $1M | · | |
| Accum. Depreciation | $613.0K | $543.0K | $482.0K | $413.0K | $462.0K | $408.0K | $371.0K | $540.0K | · | |
| Other Non-current Assets | $208.0K | $215.0K | $216.0K | $227.0K | $237.0K | $239.0K | $240.0K | · | · | |
| Total Assets | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Accounts Payable | $6M | $3M | $3M | $5M | $1M | $4M | $2M | $2M | · | |
| Current Liabilities | $19M | $16M | $20M | $24M | $23M | $24M | $28M | $19M | · | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $3M | $0 | · | · | |
| Total Liabilities | $22M | $19M | $23M | $28M | $27M | $31M | $35M | $24M | · | |
| Long-term Debt | · | · | $3M | $4M | $6M | $7M | $9M | $10M | · | |
| Total Debt | $0 | $1M | · | $4M | $6M | $7M | · | $10M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | · | $0 | · | · | |
| Paid-in Capital | $757M | $735M | $605M | $585M | $582M | $579M | $576M | $545M | · | |
| Retained Earnings | $-382M | $-356M | $-333M | $-307M | $-287M | $-266M | $-253M | $-232M | · | |
| AOCI | $-478.0K | $73.0K | $278.0K | $275.0K | $212.0K | $264.0K | $245.0K | $109.0K | · | |
| Stockholders' Equity | $375M | $379M | $272M | $277M | $295M | $313M | $323M | $314M | · | |
| Liabilities + Equity | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Shares Outstanding | 45,776,902 | 44,386,785 | 37,386,908 | 35,850,037 | 35,850,037 | 35,850,037 | 35,850,037 | 34,196,821 | · |
Cashflow 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Operating Cash Flow | $-19M | $-24M | $-28M | $-16M | $-20M | $-17M | $-5M | $-15M | $-16M | |
| CapEx | $328.0K | $26.0K | $112.0K | $22.0K | $159.0K | $426.0K | $26.0K | $305.0K | $35.0K | |
| Investing Cash Flow | $-165M | $-47M | $-14M | $13M | $-16M | $-78M | $-26.0K | $-305.0K | $-35.0K | |
| Financing Cash Flow | $16M | $124M | $16M | $-2M | $-2M | $-2M | $25M | $191M | $-2M | |
| Net Change in Cash | $-168M | $53M | $-27M | $-5M | $-37M | $-97M | $20M | $175M | $-18M | |
| Free Cash Flow | · | $-24M | · | · | · | $-18M | · | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| Net Margin | -1064.8% | -802.8% | · | -982.0% | -894.0% | -891.0% | · | · | · | |
| EBITDA Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| ROA | -7.3% | -6.0% | · | -6.3% | -13.4% | -7.5% | · | -13.9% | · | |
| ROE | -7.8% | -6.4% | · | -6.8% | -14.6% | -8.3% | · | -14.9% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.2 | 24.8 | · | 11.9 | 13.2 | 13.7 | · | 17.6 | · | |
| Quick Ratio | 16.6 | 24.3 | · | 11.7 | 13.0 | 13.5 | · | 17.5 | · | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 4.0 | 5.2 | · | 8.0 | 8.0 | 8.0 | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $9M | · | $6M | $4M | · | · | · | · | |
| Net Income TTM | $-90M | $-77M | · | $-78M | $-71M | $-63M | · | $-65M | · | |
| Market Cap | $1.12B | $776M | · | $211M | $148M | $135M | · | $711M | · | |
| Enterprise Value | $803M | $394M | · | $-71M | $-144M | $-179M | · | $387M | · | |
| P/E | -10.8 | -8.6 | · | -0.7 | -0.3 | -0.2 | · | -0.7 | · | |
| P/S | 115.8 | 89.3 | · | 35.6 | 38.3 | · | · | · | · | |
| P/B | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Tangible Book | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Cash Flow | · | -32.3 | · | · | · | -7.8 | · | · | · | |
| P / FCF | · | -32.3 | · | · | · | -7.6 | · | · | · | |
| EV / EBITDA | -27.4 | -15.5 | · | 3.1 | 5.8 | 10.9 | · | -15.6 | · | |
| EV / FCF | · | -16.4 | · | · | · | 10.0 | · | · | · | |
| EV / Revenue | 82.9 | 45.4 | · | -12.0 | -37.2 | · | · | · | · | |
| Earnings Yield | -9.2% | -11.7% | · | -139.8% | -377.7% | -605.3% | · | -149.7% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Umsatz | $9M | $0 | — |
| Betriebsgewinnmarge % | -1031.5% | — | — |
| Nettoergebnis | $-81M | $-71M | $-64M |
| Verwässerte EPS | $-2.24 | $-6.63 | $-38.17 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | 0.0 | — |
| Liquiditätsgrad | 14.2 | 12.9 | — |
| Quick Ratio | 14.0 | 12.8 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-82M | $-52M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 169 Einreicher · $825.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 42 (-7 vs. Vorquartal) | 19 (+3 vs. Vorquartal) | 51 (+7 vs. Vorquartal) | 43 (+18 vs. Vorquartal) | +3.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| a16z Capital Management, L.L.C. | $79.244.997 | 3.233.170 | 9,60% | Aktien |
| Cormorant Asset Management, LP | $58.593.729 | 2.390.605 | 7,10% | Aktien |
| Sofinnova Investments, Inc. | $56.220.744 | 2.293.788 | 6,81% | Aktien |
| Octagon Capital Advisors LP | $42.843.480 | 1.748.000 | 5,19% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $40.972.092 | 1.671.648 | 4,96% | Aktien |
| MPM BIOIMPACT LLC | $40.874.371 | 1.667.661 | 4,95% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $37.848.685 | 1.544.214 | 4,59% | Aktien |
| JANUS HENDERSON GROUP PLC | $36.597.368 | 2.094.270 | 4,43% | Aktien |
| Polar Capital Holdings Plc | $26.283.151 | 1.072.344 | 3,18% | Aktien |
| BRAIDWELL LP | $25.321.992 | 1.033.129 | 3,07% | Aktien |
| STATE STREET CORP | $25.036.083 | 1.021.464 | 3,03% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $21.542.373 | 878.729 | 2,61% | Aktien |
| Sands Capital Alternatives, LLC | $19.273.512 | 786.353 | 2,34% | Aktien |
| ORBIMED ADVISORS LLC | $18.435.270 | 752.153 | 2,23% | Aktien |
| Balyasny Asset Management L.P. | $17.227.050 | 702.858 | 2,09% | Aktien |
| D. E. Shaw & Co., Inc. | $16.771.139 | 684.257 | 2,03% | Aktien |
| VANGUARD GROUP INC | $16.418.324 | 1.240.992 | 1,99% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $16.014.197 | 653.374 | 1,94% | Aktien |
| COSMIC MANAGEMENT, LLC | $12.299.927 | 501.833 | 1,49% | Aktien |
| STEMPOINT CAPITAL LP | $11.376.831 | 464.171 | 1,38% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.053.144 | 410.165 | 1,22% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $9.242.353 | 377.085 | 1,12% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $8.778.158 | 358.146 | 1,06% | Aktien |
| Walleye Capital LLC | $8.686.221 | 354.395 | 1,05% | Aktien |
| Integral Health Asset Management, LLC | $7.353.000 | 300.000 | 0,89% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.353.000 | 300.000 | 0,89% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.267.215 | 296.500 | 0,88% | Kaufoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6.700.323 | 273.371 | 0,81% | Aktien |
| Comprehensive Financial Management LLC | $6.662.847 | 271.842 | 0,81% | Aktien |
| BANK OF AMERICA CORP /DE/ | $6.320.026 | 257.855 | 0,77% | Aktien |
| Squadron Capital Management LLC | $6.127.500 | 250.000 | 0,74% | Kaufoption |
| MILLENNIUM MANAGEMENT LLC | $5.456.441 | 222.621 | 0,66% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $5.382.396 | 219.600 | 0,65% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $5.237.076 | 213.671 | 0,63% | Aktien |
| DIADEMA PARTNERS LP | $4.904.451 | 200.100 | 0,59% | Kaufoption |
| Ikarian Capital, LLC | $4.901.999 | 200.000 | 0,59% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.599.081 | 187.641 | 0,56% | Aktien |
| FMR LLC | $4.499.129 | 183.563 | 0,55% | Aktien |
| Yiheng Capital Management, L.P. | $4.179.739 | 170.532 | 0,51% | Aktien |
| MORGAN STANLEY | $4.071.430 | 166.113 | 0,49% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $4.061.307 | 165.700 | 0,49% | Aktien |
| Squadron Capital Management LLC | $3.799.050 | 155.000 | 0,46% | Aktien |
| DIADEMA PARTNERS LP | $3.586.646 | 146.334 | 0,43% | Aktien |
| Ensign Peak Advisors, Inc | $3.473.018 | 141.698 | 0,42% | Aktien |
| UBS Group AG | $2.522.716 | 102.926 | 0,31% | Aktien |
| NEXTBio Capital Management LP | $2.468.941 | 100.732 | 0,30% | Aktien |
| Burkehill Global Management, LP | $2.451.000 | 100.000 | 0,30% | Aktien |
| Alessandra Capital Management, LLC | $2.288.459 | 93.368 | 0,28% | Aktien |
| CITADEL ADVISORS LLC | $1.920.726 | 78.365 | 0,23% | Aktien |
| Caption Management, LLC | $1.838.250 | 75.000 | 0,22% | Kaufoption |
| BNP PARIBAS FINANCIAL MARKETS | $1.752.146 | 71.487 | 0,21% | Aktien |
| Birchview Capital, LP | $1.691.190 | 69.000 | 0,20% | Aktien |
| Squarepoint Ops LLC | $1.677.366 | 68.436 | 0,20% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.504.767 | 61.394 | 0,18% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.504.424 | 61.380 | 0,18% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.450.943 | 59.198 | 0,18% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.431.384 | 58.400 | 0,17% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.422.193 | 58.025 | 0,17% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $1.342.658 | 54.780 | 0,16% | Aktien |
| Quantinno Capital Management LP | $1.254.618 | 51.188 | 0,15% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $1.225.500 | 50.000 | 0,15% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.214.348 | 49.545 | 0,15% | Aktien |
| Moody Aldrich Partners LLC | $1.164.004 | 47.491 | 0,14% | Aktien |
| SIMPLEX TRADING, LLC | $1.158.832 | 47.280 | 0,14% | Aktien |
| Bank of New York Mellon Corp | $1.118.416 | 45.631 | 0,14% | Aktien |
| RHUMBLINE ADVISERS | $1.076.080 | 43.904 | 0,13% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.029.420 | 42.000 | 0,12% | Aktien |
| Corient Private Wealth LP | $986.724 | 40.778 | 0,12% | Aktien |
| BlackRock, Inc. | $985.400 | 40.204 | 0,12% | Aktien |
| Persistent Asset Partners Ltd | $913.071 | 37.253 | 0,11% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $866.183 | 35.340 | 0,10% | Aktien |
| DEUTSCHE BANK AG\ | $840.644 | 34.298 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $799.293 | 45.700 | 0,10% | Aktien |
| CITADEL ADVISORS LLC | $794.124 | 32.400 | 0,10% | Verkaufsoption |
| Militia Capital Management LLC | $791.330 | 32.286 | 0,10% | Aktien |
| Vanguard Global Advisers, LLC | $781.011 | 31.865 | 0,09% | Aktien |
| MARSHALL WACE, LLP | $778.021 | 31.743 | 0,09% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $735.349 | 30.002 | 0,09% | Aktien |
| CITIGROUP INC | $697.138 | 28.443 | 0,08% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $689.883 | 28.147 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $681.378 | 27.800 | 0,08% | Kaufoption |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $681.084 | 27.788 | 0,08% | Aktien |
| XTX Topco Ltd | $656.696 | 26.793 | 0,08% | Aktien |
| WEXFORD CAPITAL LP | $631.500 | 25.765 | 0,08% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $612.750 | 25.000 | 0,07% | Kaufoption |
| JANE STREET GROUP, LLC | $590.421 | 24.089 | 0,07% | Aktien |
| Caption Management, LLC | $569.612 | 23.240 | 0,07% | Aktien |
| STRS OHIO | $539.220 | 22.000 | 0,07% | Aktien |
| BARCLAYS PLC | $538.779 | 21.982 | 0,07% | Aktien |
| Militia Capital Partners, LP | $533.169 | 40.300 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $511.989 | 20.889 | 0,06% | Aktien |
| Stonepine Capital Management, LLC | $490.200 | 20.000 | 0,06% | Aktien |
| BANK OF NOVA SCOTIA | $490.200 | 20.000 | 0,06% | Aktien |
| Man Group plc | $444.783 | 18.147 | 0,05% | Aktien |
| Virtus Investment Advisers, LLC | $444.538 | 18.137 | 0,05% | Aktien |
| Verdad Advisers, LP | $426.327 | 17.394 | 0,05% | Aktien |
| JANE STREET GROUP, LLC | $409.317 | 16.700 | 0,05% | Verkaufsoption |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $396.743 | 16.187 | 0,05% | Aktien |
| GREAT LAKES ADVISORS, LLC | $390.493 | 15.932 | 0,05% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $373.532 | 15.240 | 0,05% | Aktien |
Unternehmensinsider 9 Insider · 3 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD | Chief Financial Officer | 23. April 2026 M | 36.575 | 0 | 4 | $-531.844 |
| Shane Barton | Principal Accounting Officer | 30. Juni 2026 M | 0 | 0 | 2 | $-1.576.885 |
| Paul D Rubin | Chief Medical Officer | 1. April 2026 M | 0 | 0 | 6 | $-1.460.917 |
| Vijay Satyanand Pande | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Rekha Hemrajani | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Michael H. Davidson | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Patrick G. Enright | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Dr. James I. Healy | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Jean Pierre Garnier | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| AH Bio Fund I, L.P., AH Equity Partners Bio I, L.L.C., AH Bio Fund III, L.P., AH Equity Partners Bio III, L.L.C., AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., Andreessen Horowitz LSV Fund III, L.P., AH Equity Partners LSV III, L.L.C., Marc Andreessen, Benjamin Horowitz | 4. Oktober 2024 | — | Erste Einreichung | Passive Anlage | SEC |
| Sofinnova Venture Partners XI, L.P. (“SVP XI”), Sofinnova Management XI, L.P. (“SM XI LP”), Sofinnova Management XI, L.L.C. (“SM XI LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) | 30. September 2024 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 36 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,81% | 6.165 NS | 30. April 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,26% | 100.818 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,16% | 127.778 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,09% | 118.766 SH | 8. August 2026 | Täglich |
| IHE · iShares Trust | 0,08% | 113.984 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 27.617 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,04% | 1.604 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 2.418 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 202.410 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,03% | 230.833 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 43.526 NS | 31. Mai 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 293.863 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 10.835 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,02% | 13.075 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1.420 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 897.031 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 142.676 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 367.869 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.710 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 79.583 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1.111 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1.121 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 12.106 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 20.675 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 31.584 SH | 8. August 2026 | Täglich |
| HDG · ProShares Trust | 0,00% | 28 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.850 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 16.108 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 45.805 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 8.951 SH | 8. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 13.304 NS | 30. April 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 1.959 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 2.074 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 893 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.140.593 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.774 SH | 8. August 2026 | Täglich |